5[1]Chalmers J,Macmahon S,Mancia G et al. WHO-ISH Hype- rtension Guidelines Committee.1999 World Health Organization -International Society of Hypertension Guidelines for the Ma- nagement of Hypertension. J Hypertens 1999;17:151～185
6[2]Muiesan ML,Salvetti M,Rizzoni D et al. Association of chang in left ventricular mass with prognosis during long term antihy- pertensive treatment. J Hypertens 1995;13:1091～1097
7[3]Burke AP,Farb A,Liang YH et al. Effect of hypertension and cardiac hypertrophy on coronary artery morphology in sudden cardiac death. Circulation 1996;94:3138～3145
8[4]Irite M,Caso R,Murga N et al. Microvascular,angina pectoris in hypertensive patients with left ventricular hypertrophy and diagnostic value of exercise thallium-201 scintigraghy. Am J Cardiol 1995; 75:335～339
9[5]Bishop SP,Powell PC,Hasebe N et al. Coronary vascular mo- rphology in pressure-overload left ventricular hypertrophy. J Mol Cell Cardiol 1996;28:141～154
10[6]Treasure CB,Klein JL,Vita JA et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium -mediated relaxation in human coronary resistance vessels. Circ- ulation 1993;87:86～93
9Esnault VL,Brown EA,Apetrei E,et al.The effects of am-lodipine and enalapril on renal function in adults with hyper-tension and nondiabetic nephropathies:a 3-year,randomized,multicenter,double-blind,placebo-controlled study.Clin T-her,2008,30(3):482.
